NASDAQ:BRZE • US10576N1028
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BRAZE INC-A (BRZE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-01-14 | Needham | Reiterate | Buy -> Buy |
| 2025-12-31 | Needham | Reiterate | Buy -> Buy |
| 2025-12-17 | BTIG | Initiate | Buy |
| 2025-12-10 | Citizens | Reiterate | Market Outperform -> Market Outperform |
| 2025-12-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-12-10 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-10 | DA Davidson | Maintains | Buy -> Buy |
| 2025-12-10 | Stifel | Maintains | Buy -> Buy |
| 2025-12-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-22 | Needham | Reiterate | Buy -> Buy |
| 2025-10-01 | Wells Fargo | Initiate | Overweight |
| 2025-10-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-09-05 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-09-05 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-09-05 | UBS | Maintains | Buy -> Buy |
| 2025-09-05 | Needham | Reiterate | Buy -> Buy |
| 2025-09-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 355.4M 49.33% | 471.8M 32.75% | 593.41M 25.78% | 745.84M 25.69% | 874.96M 17.31% | 1.02B 16.58% | 1.198B 17.45% | 1.374B 14.69% | |
| EBITDA YoY % growth | -143.48M -90.22% | -131.377M 8.44% | -108.168M 17.67% | 40.328M 137.28% | 75.889M 88.18% | 124.88M 64.56% | 223.28M 78.80% | 312.32M 39.88% | |
| EBIT YoY % growth | -148.1M -89.39% | -138.34M 6.59% | -118.283M 14.50% | 26.958M 122.79% | 66.106M 145.22% | 114.27M 72.86% | 202.98M 77.63% | 271.32M 33.67% | |
| Operating Margin | -41.67% | -29.32% | -19.93% | 3.61% | 7.56% | 11.20% | 16.94% | 19.75% | |
| EPS YoY % growth | -0.64 26.62% | -0.26 59.38% | 0.18 169.23% | 0.43 138.75% | 0.65 50.21% | 1.00 54.95% | 1.40 39.71% | 1.87 33.58% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.14 16.70% | 0.12 67.37% | 0.16 5.69% | 0.16 165.03% | 0.21 53.15% | 0.20 72.26% | 0.25 55.24% | 0.24 53.03% | 0.32 49.95% |
| Revenue Q2Q % growth | 202.17M 26.04% | 201.2M 24.15% | 214.64M 19.17% | 224.56M 17.67% | 233.52M 15.51% | 235.04M 16.82% | 249.55M 16.26% | 262.14M 16.73% | 273.75M 17.23% |
| EBITDA Q2Q % growth | 16.055M 255.39% | 12.483M 145.23% | 18.114M 160.42% | 17.918M 175.52% | 25.892M 61.27% | 24.098M 93.05% | 31.848M 75.82% | 29.918M 66.97% | 40.722M 57.28% |
| EBIT Q2Q % growth | 12.871M 162.95% | 10.93M 136.19% | 15.817M 142.35% | 16.164M 143.59% | 22.92M 78.07% | 21.298M 94.86% | 26.861M 69.82% | 27.754M 71.70% | 37.415M 63.24% |
All data in USD
27 analysts have analysed BRZE and the average price target is 43.75 USD. This implies a price increase of 133.1% is expected in the next year compared to the current price of 18.77.
BRAZE INC-A (BRZE) will report earnings on 2026-03-24, after the market close.
The consensus EPS estimate for the next earnings of BRAZE INC-A (BRZE) is 0.14 USD and the consensus revenue estimate is 202.17M USD.
The expected long term growth rate for BRAZE INC-A (BRZE) is 19.31%.